$9.7bn AI Cloud Contract with Microsoft NASDAQ: IREN November 3, 2025 DISCLAIMER Forward-Looking Statements This investor update includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"), that involve substantial risks and uncertainties. Forward-looking statements include information concerning possible or assumed future results of operations, includin ...

（文章来源：每日经济新闻） 每经AI快讯，11月3日，IREN美股盘前直线拉升涨21%。 ...

格隆汇11月3日｜IREN美股盘前直线拉升涨超14%，消息面上，公司与微软签署97亿美元协议，将在德 克萨斯州提供云计算服务。 ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced it has signed a multi-year GPU cloud services contract with Microsoft. Under the agreement, IREN will provide Microsoft with access to NVIDIA GB300 GPUs over a five-year term, with a total contract value of approximately $9.7 billion, including a 20% prepayment. IREN has also entered into an agreement with Dell Technologies to purchase the GPUs and ancillary equipment for approximately $5.8 billion.1 The GPUs ar ...

Key Points Bitcoin has produced tremendous long-term returns, but the next wave of gains may come from crypto stocks. Crypto stocks benefit from rising Bitcoin prices but have underlying businesses that go beyond buying and holding crypto. IREN and Coinbase have outperformed Bitcoin year-to-date and have plenty of tailwinds that support long-term growth. 10 stocks we like better than Iren › Bitcoin (CRYPTO: BTC) is approaching an all-time high as investors get more enthusiastic about cryptocurrenc ...

Key Takeaways IREN doubled its AI cloud capacity to 23k GPUs with a $674 million purchase of NVIDIA and AMD chips. Customer contracts for 11k GPUs support $225 million in AI Cloud ARR, targeting $500 million by fiscal 2026. IREN shares have jumped 502.7% YTD, with the stock trading at a 63.42X price/cash flow multiple. IREN Limited’s (IREN) AI cloud business is expanding rapidly. IREN has doubled its AI cloud capacity to 23k GPUs through the purchase of an additional 12.4k GPUs for roughly $674 million. Thi ...

Key Takeaways Applied Digital's CoreWeave lease deal secures $11B in projected revenues and de-risks its business.IREN targets $1.25B in annualized revenues, with $500M AI Cloud ARR expected by early fiscal 2026. APLD shares surged 49.7% in a month, outpacing IREN's 33% gain, signaling stronger investor momentum. Applied Digital (APLD) and IREN Limited (IREN) offer next-gen data center infrastructure targeting high-performance computing (HPC), artificial intelligence (AI) workloads and scalable computing. D ...

IREN Limited ( IREN ) failed to break through a psychological level of $70 per share a couple of weeks ago and it currently trades at $62. The current 13% short interest is quite high, but I think that the stockComing from an IT background, I have dived into the U.S. stock market seven years ago by managing portfolio of my family. Starting managing real money has been challenging for the first time, but long hours of mastering fundamental analysis of public companies paid off and now I feel very confident i ...

市场表现 - 加密货币相关股票周一普遍上涨 Robinhood上涨5% Hut 8、CleanSpark和IREN等比特币矿工/AI基础设施公司涨幅在2%-3%之间 Eric Trump领导的American Bitcoin因宣布收购1,414枚比特币持仓增至3,865枚而大涨10.5% [2][3] - 稳定币发行商Circle表现落后下跌2.3% [3] - 传统市场同样飙升纳斯达克指数上涨1.5%标准普尔500指数上涨1% [3] - 此前火热的贵金属继续失宠黄金下跌3.2%白银下跌4.5% [3] 贸易谈判进展 - 美国总统特朗普表示对达成协议感觉良好该协议将允许中国继续向美国供应稀土磁体以换取缓解本月早些时候宣布的100%关税威胁 [1] - 美国财长Scott Bessent周末的积极评论推动比特币在周日飙升至116,200美元随后小幅回落至115,000美元 [2] - 特朗普定于周四与中国国家主席习近平会面稀土元素是谈判的核心部分中国控制着全球约70%的稀土产量这些材料用于电动汽车电机、风力涡轮机和军事装备 [4] 宏观经济背景 - 交易商为美联储即将做出的政策决定做准备市场普遍预期央行将基准利率下调25个基点这一举措将降低借贷成本并可能刺激对加密货币和科技股等资产的风险偏好 [5]

Earnings are just around the corner for IREN Limited (NASDAQ: IREN ), and with analysts projecting quite a bit of growth, I thought it would be useful to break down the full portfolio ofI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behi ...